Teva Baltics/Sicor Biotech is a biotech pharmaceutical company that develops and produces recombinant biopharmaceuticals using advanced research and production technologies as well as distributes Teva drug products in the Baltic countries. Sicor Biotech belongs to the group of companies of Teva Pharmaceutical Industries Ltd., which is one of the top ten largest pharmaceutical companies worldwide, and is focused on the production of specialty, generic and OTC medicines.
Since setting up in Lithuania, the company has significantly expanded their operational capabilities in biopharmacy by investing more than $80 million, and has recently installed brand new laboratories and manufacturing lines. This has allowed them to increase the number of employees to almost 200, the majority of whom are highly qualified natural science and engineering specialists with bachelor’s or master’s degrees in life sciences. More than 98% of products manufactured by the company are exported to over 50 countries, with the majority going to the EU, USA and Japan.
